Cleveland Clinic is launching the Quantum Innovation Catalyzer Program, a chance for start-up companies in healthcare technology and life sciences to gain experience with quantum computing and apply it to their research and development work under expert guidance.Read More
According to County Health Rankings, 80% of population health is related to social, economic, environmental and behavioral factors, versus 20% attributed to medical care. Cleveland Clinic’s Community Care Medical Director explains the importance of community health efforts and talks about response efforts to the COVID-19 pandemic.
Cleveland Clinic has launched a new website for employers that offers expert insight and resources for safely resuming operations in the era of COVID-19.
Don’t take a near-term rise in newly confirmed cases as a sign that social distancing isn’t having an impact, our CEO cautions. Lessons from the 1918 influenza pandemic support continued separation for now.
Cleveland Clinic announced the appointment of Thomas E. Mroz, MD, as chair of the Orthopaedic & Rheumatologic Institute. Dr. Mroz, who specializes in minimally invasive surgery and cervical spine surgery, will oversee more than 478 caregivers and 125 staff physicians in the institute.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
After nearly five years at Press Ganey, James Merlino, MD, returns to Cleveland Clinic as its inaugural Chief Clinical Transformation Officer. In this article, Dr. Merlino explains how he will use his past experiences to help execute Cleveland Clinic’s bold strategic vision.
SGLT2 inhibitors for heart failure with preserved ejection fraction will be the No. 10 most influential medical innovation for 2020, predict experts at Cleveland Clinic.
PARP inhibitors for maintenance therapy in ovarian cancer will be the No. 9 most influential medical innovation for 2020, predict experts at Cleveland Clinic.
Bempedoic acid for statin-intolerant patients will be the No. 8 most influential medical innovation for 2020, predict experts at Cleveland Clinic.
An antibiotic envelope to help prevent infection of cardiac implantable devices will be the No. 7 most influential medical innovation for 2020, predict experts at Cleveland Clinic.
Romosozumab, a dual-acting drug to treat osteoporosis, will be the No. 1 most influential medical innovation for 2020, predict experts at Cleveland Clinic.